Who
James P. Mackin
President & CEO
Company insider
Files Form 4 as: President & CEO, Artivion; Director, Wright Medical Group; SVP & Pres CRDM, Medtronic.
In numbers
- Trades disclosed
- 195
- Buys
- 4
- Sells
- 36
- Bought
- $352K
- Sold
- $35.7M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 22 Oct 2007
- Last trade
- 19 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 20 Aug 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $2.0M70,000 at $28.96 | filing |
| 19 Aug 2026filed 20 Aug 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $2.0M70,000 at $28.96 | filing |
| 3 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $676K17,887 at $37.78 | filing |
| 3 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $676K17,887 at $37.78 | filing |
| 2 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —116,948 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —116,948 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $567K14,911 at $38.02 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $567K14,911 at $38.02 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $497K13,936 at $35.69 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —97,030 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $497K13,936 at $35.69 | filing |
| 24 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —97,030 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $788K20,962 at $37.59 | filing |
| 23 Feb 2026filed 25 Feb 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $788K20,962 at $37.59 | filing |
| 3 Dec 2025filed 4 Dec 2025 | AORT Artivionoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,921 at $0.00 | filing |
| 3 Dec 2025filed 4 Dec 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Code M | $916K30,921 at $29.62 | filing |
| 3 Dec 2025filed 4 Dec 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $1.4M30,921 at $45.46 | filing |
| 2 Dec 2025filed 3 Dec 2025 | AORT Artivionoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,921 at $0.00 | filing |
| 2 Dec 2025filed 3 Dec 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Code M | $916K30,921 at $29.62 | filing |
| 2 Dec 2025filed 3 Dec 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Sold | $1.4M30,921 at $45.56 | filing |
News
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial ResultsAORT · prnewswire.com · 22 Oct 2026
0 headlines in the last 90 days name James P. Mackin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.